Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL) 1 mg

Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

US$178.10

Excluding tax and shipping fees

In stock

Description

About Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

The Human Envelope protein Peptide is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Envelope protein Peptide, H-QIFEASKAHL-OH (Uniprot: O42043 aa: 485-494) from JPT is produced under strict quality control and quality management.

Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL) - Specifications

Peptide sequence: H-QIFEASKAHL-OH

Amount: 1 mg

Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)

Delivery Format: Freeze-dried in plastic vial

Application(s): T-cell immunity

Condition(s)/Topic(s): Autoimmune disease

Standard Delivery Time: approx. 10 days

Your Custom or Scrambled Antigen Peptide!

Do you need a scrambled version of this antigen peptide?We can produce scrambled versions for all our antigen peptides and other peptide sequences. These scrambled peptide versions are cross-checked against the Uniprot database to ensure that the scrambled sequence does not correspond to any natural sequence. Have a look at Scrambled Antigen Peptides!

Are you interested in other antigen peptides?Choose sequence, amount and purity. We will assist you along the way: Custom Peptide Synthesis

JPT’s Antigen PeptidesFind your antigen peptide and select the connected PepMix™ Peptide Pool and MHC Multimer for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides- All peptides are made in Germany- Bulk orders or custom peptide snythesis upon request- Synthesis protocols designed to avoid toxic contaminants and side products - Provision of freeze dried aliquots for enhanced stability - Proven track record for applications in clinical studies- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

References:Read References with Antigen Peptides

Testimonials "To establish a novel role for myeloid derived suppressor cells (Pallett et al, Nat. Med. 2015) in chronic viral infection, we utilised the PepMix CEF Pool (extended) as well as a custom synthesized PepMix spanning the core region of HBV genotype D . Whereas, the CEF peptide pool consists of 32 peptides, each corresponding to a defined HLA class I-restricted T-cell epitope from Cytomegalo, Epstein-Barr, and Influenza virus, the latter custom PepMix included 15meric peptides overlapping by 10 amino acids. Specifically this composition enabled us to monitor both the antiviral CD8+ and CD4+ T cell responses in chronic HBV infection and the non-antigen specific T cells that are known to mediate immunopathology in the liver. Our entire experience with JPT, from ordering/delivery to use in the lab was excellent. Not only were the reagents able to perform reliably and consistently in vitro from batch to batch, the customer and technical support provided was continually available and efficient when needed. JPT will remain our go-to company for purchasing peptides." Dr. Laura J Pallett, Infection and Immunity, University College London, UK

Documentation

Documentation for Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

Protocol_PepMix.pdf

Envelope-protein-QIFEASKAHL-2.pdf

Properties

Properties of Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

T-cell immunity

Antigen Peptides

Autoimmune disease

Freeze-dried in plastic vial

Human

Envelope protein

Trial Grade: each peptide purified to > 90% (HPLC/MS)

No

Further Information to Antigen Peptide Envelope protein HLA-A*0201 (QIFEASKAHL)

Values

H-QIFEASKAHL-OH

10mer peptide as TFA salt